Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Javier López-Longo
Independent Candidate Serum Protein Biomarkers of Response to Adalimumab and to Infliximab in Rheumatoid Arthritis: An Exploratory Study
PLoS ONE
Multidisciplinary
Related publications
The Combined Use of Disease Activity and Infliximab Serum Trough Concentrations for Early Prediction of (Non-)Response to Infliximab in Rheumatoid Arthritis
British Journal of Clinical Pharmacology
Pharmacology
Circulating Th17.1 Cells as Candidate for the Prediction of Therapeutic Response to Abatacept in Patients With Rheumatoid Arthritis: An Exploratory Research
PLoS ONE
Multidisciplinary
Increase in Methotrexate Dose in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Infliximab
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Infliximab in Active Early Rheumatoid Arthritis
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Infliximab as Alternative Therapy in Renal AA Amyloidosis Secondary to Rheumatoid Arthritis
Austin Journal of Nephrology and Hypertension
To Study the Serum Vitamin –D and Oxidative Stress Status in Rheumatoid Arthritis
Journal of Current Medical Research and Opinion
Adalimumab in the Treatment of Early Rheumatoid Arthritis
Nauchno-Prakticheskaya Revmatologiya
Rheumatology
Allergy
Immunology
Serum ADA and C-Reactive Protein in Rheumatoid Arthritis
International Journal of Human Genetics
Genetics
Cost-Effectiveness of Abatacept Compared to Adalimumab in Italy Based on a Head-To-Head Outcomes Study in Rheumatoid Arthritis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
